Target intelligence / Profile preview

E3 ubiquitin-protein ligase NEDD4 (NEDD4)

Target
NEDD4
Molecular classification
Enzyme, E3 ubiquitin ligase, HECT domain-containing protein
01

Overview

E3 ubiquitin-protein ligase NEDD4 is an enzyme encoded by the human *NEDD4* gene. It is a founding member of the HECT domain-containing family of E3 ubiquitin ligases. The primary function is to catalyze the transfer of ubiquitin from an E2 conjugating enzyme to specific substrate proteins—most notably various ion channels and membrane receptors—marking them for endocytosis and proteasomal degradation. Through these actions, it regulates key cellular processes including signal transduction pathways (such as insulin-like growth factor signaling), neuronal architecture during brain development, receptor downregulation (including EGFR family members), bone formation/remodeling, viral budding mechanisms for several viruses via matrix protein modification, among others. Dysregulation has been implicated in cancer progression—where it can promote tumorigenesis by degrading tumor suppressor substrates—as well as developmental disorders affecting neural tissues and mineralized tissues like bone and teeth.

Other names
Neural precursor cell expressed developmentally down-regulated protein 4NEDD4 ubiquitin-protein ligaseNedd4 (gene/protein symbol)
02

Mechanism of action

Drugs or molecules targeting NEDD4 typically act by inhibiting its E3 ligase activity, thereby preventing the ubiquitination and subsequent degradation or endocytosis of its substrate proteins. This can modulate pathways involved in cell proliferation, survival, or receptor signaling.

03

Biological functions

Ubiquitination of target proteinsRegulation of membrane protein turnover (ion channels, receptors)Endocytosis and degradation of membrane proteinsSignal transduction regulation (e.g., insulin-like growth factor signaling, EGF pathway)Neuronal development and architectureViral budding via modification of viral matrix proteins
04

Disease associations

Cancer (notably hepatocellular carcinoma and other malignancies)Neurodevelopmental disordersBone and tooth development abnormalities
05

Safety considerations

Potential safety concerns include disruption of normal protein homeostasis leading to unintended effects on essential cellular processes such as neuronal function, immune response, or tissue development.Inhibition could affect multiple substrates due to the broad specificity of this enzyme family.Off-target effects remain a challenge.
06

Interacting drugs

There are small molecule inhibitors under investigation that target the activity of NEDD4, but no widely approved drugs specifically targeting this enzyme are currently in clinical use. Research is ongoing to develop such inhibitors for cancer therapy and other indications.
07

Biomarkers

NEDD4 expression levels may serve as a biomarker for certain cancers (such as hepatocellular carcinoma) due to its role in promoting tumor cell proliferation through substrate degradation.Its expression may also be relevant in bone diseases or neurodevelopmental conditions.

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase NEDD4 (NEDD4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase NEDD4 (NEDD4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call